Meningitis, Cryptococcal. Cerebral Cryptococcosis . Cerebral Cryptococcoses . Cerebral Cryptococcoses, Granulomous . Cerebral Cryptococcosis, Granulomous . Cryptococcal Meningitides . Cryptococcoses, Cerebral . Cryptococcoses, Granulomous Cerebral . Cryptococcosis, Cerebral . Cryptococcosis, Granulomous Cerebral . Granulomous Cerebral Cryptococcoses . Meningitides, Cryptococcal . Torulomas . Cryptococcal Meningitis . Granulomous Cerebral Cryptococcosis . Toruloma . Meningeal inflammation produced by CRYPTOCOCCUS NEOFORMANS, an encapsulated yeast that tends to infect individuals with ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunocompromised states. The organism enters the body through the respiratory tract, but symptomatic infections are usually limited to the lungs and nervous system. The organism may also produce parenchymal brain lesions (torulomas). Clinically, the course is subacute and may feature HEADACHE; NAUSEA; PHOTOPHOBIA; focal neurologic deficits; SEIZURES; cranial neuropathies; and HYDROCEPHALUS. (From Adams et al., Principles of Neurology, 6th ed, pp721-2) . 0.43
Triacetin. Enzactin . Triacetyl-glycerol . Triacetyl glycerol . Triacetylglycerol . A triglyceride that is used as an antifungal agent. . 0.36
Antifungal Agents. Antibiotics, Antifungal . Therapeutic Fungicides . Agents, Antifungal . Antifungal Antibiotics . Fungicides, Therapeutic . Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. . 0.35
Cryptococcus. Torulas . Torula . A mitosporic Tremellales fungal genus whose species usually have a capsule and do not form pseudomycellium. Teleomorphs include Filobasidiella and Fidobasidium. . 0.34
